seckljpg Michael Seckl Clinical Director, ECMC


Michael Seckl became a Reader and FRCP at Imperial College London in 2000 and Professor in 2002 and currently heads up Molecular Oncology with its associated Lung Cancer Research team. Within Imperial College, he is the Director of Post Graduate Studies for the Dept of Surgery and Cancer and he leads the Imperial Experimental Cancer Medicine Centre. In the NHS, he is Director of the Charing Cross/ Imperial College Trophoblastic Disease and Malignant Ovarian Germ Cell Tumour (MOGCT) Centre and supraregional tumour marker assay service. He is an international leader in trophoblastic disease and MOGCT, is a past-president of the International Trophoblastic Disease Society (, and is president-elect and a founding member of council of the European Organisation for the Treatment of Trophoblastic Disease (, is a visiting Professor at Peking Union Medical College and serves on several editorial boards and grants committees. He leads the gynae cancer theme of the European Rare Adult Cancer Reference Network (EURACAN).